title: Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
abstract: OBJECTIVE
  Preoperative short-term radiotherapy improves local control in patients treated with total mesorectal excision (TME). This study was performed to assess the presence and magnitude of long-term side effects of preoperative 5 x 5 Gy radiotherapy and TME. Also, hospital treatment was recorded for diseases possibly related to late side effects of rectal cancer treatment.
  
  
  METHODS
  Long-term morbidity was assessed in patients from the prospective randomized TME trial, which investigated the efficacy of 5 x 5 Gy before TME surgery for mobile rectal cancer. Dutch patients without recurrent disease were sent a questionnaire.
  
  
  RESULTS
  Results were obtained from 597 patients, with a median follow-up of 5.1 years. Stoma function, urinary function, and hospital treatment rates did not differ significantly between the treatment arms. However, irradiated patients, compared with nonirradiated patients, reported increased rates of fecal incontinence (62% v 38%, respectively; P < .001), pad wearing as a result of incontinence (56% v 33%, respectively; P < .001), anal blood loss (11% v 3%, respectively; P = .004), and mucus loss (27% v 15%, respectively; P = .005). Satisfaction with bowel function was significantly lower and the impact of bowel dysfunction on daily activities was greater in irradiated patients compared with patients who underwent TME alone.
  
  
  CONCLUSIONS
  Although preoperative short-term radiotherapy for rectal cancer results in increased local control, there is more long-term bowel dysfunction in irradiated patients than in patients who undergo TME alone. Rectal cancer patients should be informed on late morbidity of both radiotherapy and TME. Future strategies should be aimed at selecting patients for radiotherapy who are at high risk for local failure.
authors.affiliation: Department of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands.
authors.forename: K C M J
authors.initials: KC
authors.lastname: Peeters
authors.forename: C J H
authors.initials: CJ
authors.lastname: van de Velde
authors.forename: J W H
authors.initials: JW
authors.lastname: Leer
authors.forename: H
authors.initials: H
authors.lastname: Martijn
authors.forename: J M C
authors.initials: JM
authors.lastname: Junggeburt
authors.forename: E Klein
authors.initials: EK
authors.lastname: Kranenbarg
authors.forename: W H
authors.initials: WH
authors.lastname: Steup
authors.forename: T
authors.initials: T
authors.lastname: Wiggers
authors.forename: H J
authors.initials: HJ
authors.lastname: Rutten
authors.forename: C A M
authors.initials: CA
authors.lastname: Marijnen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D019583:Dose Fractionation, Radiation; D005242:Fecal Incontinence / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D020360:Neoadjuvant Therapy; D017060:Patient Satisfaction; D011832:Radiation Injuries / Q000209:etiology* / Q000473:pathology*; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*